The in vivo and in vitro occupation of [3H]-spiperone binding sites in the frontal cortex and striatum by putative 5-hydroxytryptamine antagonists.
D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D002090:Butyrophenones / Q000378:metabolism*; D002540:Cerebral Cortex / Q000378:metabolism*; D003342:Corpus Striatum / Q000378:metabolism*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008566:Membranes / Q000378:metabolism; D011619:Psychotropic Drugs / Q000378:metabolism; D051381:Rats; D012702:Serotonin Antagonists / Q000378:metabolism*; D013134:Spiperone / Q000378:metabolism*; D013997:Time Factors
D002090:Butyrophenones; D011619:Psychotropic Drugs; D012702:Serotonin Antagonists; D013134:Spiperone